Issn  2249-7579
e Issn  2249-7579
Publisher JOURNAL OF PHARMACEUTICAL BIOLOGY

CLINICAL SIGNIFICANCE OF HALF LIFE OF DRUGS

Raj Kumar Goel
Department of Pharmacology, Hind Institute of Medical Sciences, Safedabad, Barabanki, UP.
Pratap Shankar
Department of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, UP – 226003.
Shazia
Department of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, UP – 226003.
Sanjay Khanna
Department of Pharmacology, Hind Institute of Medical Sciences, Safedabad, Barabanki, UP.
Rakesh Kumar Dixit
Department of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, UP – 226003.

Pharmacokinetics ,Half-life ,Drug ,

Half life of drug is a pharmacokinetic property of the drug. For any given drug and dose, the plasma concentration of the drug will rise and fall according to the rates of three processes: absorption, distribution, and elimination. The half-life of a drug is the time it takes for its concentration in blood or plasma to decrease by half. The time required for any plasma concentration of drug to fall by 50% is known as half- life of that drug (T1/2). In this review we summarized about the half-life of the drug.

4 , 1 , 2014

6 - 7